On Assignment (ASGN) : During the past 4 weeks, traders have been relatively bearish on On Assignment (ASGN), hence the stock is down -4.54% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -2.89% relative to the S&P 500. The 4-week change in the price of the stock is -5.05% and the stock has fallen -2.73% in the past 1 week.
The stock has recorded a 20-day Moving Average of 2.21% and the 50-Day Moving Average is 2.42%.The 200 Day SMA reached 1.74%
On Assignment (NYSE:ASGN): After opening at $36.37, the stock dipped to an intraday low of $35.78 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $36.5 and the buying power remained strong till the end. The stock closed at $36.29 for the day, a gain of 0.67% for the day session. The total traded volume was 599,227. The stocks close on the previous trading day was $36.29.
On Assignment (ASGN) : 6 Wall Street analysts covering On Assignment (ASGN) believe that the average level the stock could reach for the short term is $43.83. The maximum price target given is $47 and the minimum target for short term is around $41, hence the standard deviation is calculated at $2.14.
On Assignment, Inc. is a global provider of professionals in the information technology (IT), engineering and life sciences sectors. The Company matches people into positions for contract, contract-to-hire and direct hire assignments. Its operating segments include Apex, Oxford and Life Sciences Europe. The Apex Segment provides information technology and scientific staffing professionals for contract, contract-to-hire and permanent placement positions. The Oxford Segment provides contract and direct placement services of information technology and engineering professionals in specialized information technology, software and hardware engineering, and mechanical, electrical, validation and telecommunications engineering fields. The Life Sciences Europe Segment provides locally-based contract life science professionals to clients in the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical, automotive, educational and environmental industries.